NCT03203499View on ClinicalTrials.gov

A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

November 15, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

ANS-6637 Oral Tablet

Ascending single doses administered orally.

DRUG

Placebo Oral Tablet

Placebo administered orally.

Trial Locations (1)

66212

Vince and Associates, Overland Park

Sponsors
All Listed Sponsors
lead

Amygdala Neurosciences, Inc.

INDUSTRY

NCT03203499 - A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol | Biotech Hunter | Biotech Hunter